Dechra reports strong 12-month business growth

Dechra has published a trading update highlighting the strong growth experienced by its business during the 12 months ending on June 30th 2012.

Preliminary figures for the fiscal year revealed that the animal health company saw annual growth of 9.3 percent during the period, which was partially driven by its recent acquisition of Eurovet Animal Health.

Its pharmaceutical division experienced particular success during the year, with growth seen across all territories, while its US operations continued to expand despite persisting supply issues.

Dechra is confident that its final results – which will be published in September 2012 – will fall in line with its expectations.

The company statement said: "The group has delivered strong growth throughout the financial year and continues to progress its strategic objectives of building a high margin, cash generative veterinary pharmaceutical business."

Last month, Dechra announced the newest phase of the It's Time to Change campaign with the launch of a new range of support materials that will help vets to educate their customers on pet ear health.